No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ELV240719P510000
- 7.77
- +2.57+49.42%
15min DelayClose Jul 19 16:00 ET
7.80High4.66Low
7.00Open5.20Pre Close47 Volume225 Open Interest510.00Strike Price31.77KTurnover204.76%IV-0.42%PremiumJul 19, 2024Expiry Date9.88Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8244Delta0.0249Gamma46.09Leverage Ratio-35.7786Theta-0.0004Rho-38.00Eff Leverage0.0131Vega
Intraday
- 5D
- Daily
News
Elevance Health Is Maintained at Buy by TD Cowen
Elevance Health Is Maintained at Buy by TD
Express News | TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
Baird Adjusts Price Target on Elevance Health to $625 From $649
Elevance Health (ELV) has an average rating of outperform and price targets ranging from $550 to $665, according to analysts by Capital IQ.Price: 503.00, Change: -1.72, Percent Change: -0.34
Elevance Health Second Quarter 2024 Earnings: EPS Beats Expectations
Express News | Elevance Health Inc : TD Cowen Cuts Target Price to $589 From $624
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
Comments
A flood of earnings will be coming over the next three weeks. This week will feature mostly financial companies.
Monday: Goldman Sachs ( $Goldman Sachs(GS.US$ ) and money manager Blackrock ( $Blackrock(BLK.US$ )
Tuesday: Health-insurer UnitedHealth Group ( $UnitedHealth(UNH.US$ ) , Bank of America ( $Bank of America(BAC.US$ ) , Morgan Stanley ( $Morgan Stanley(MS.US$ ) and Charles Schwab ( $Charles Schwab(SCHW.US$ ) .
Wednesday: Chip-equipment maker ASML ( $ASML Holding(ASML.US$ ) , pharm...
Monday: Goldman Sachs ( $Goldman Sachs(GS.US$ ) and money manager Blackrock ( $Blackrock(BLK.US$ )
Tuesday: Health-insurer UnitedHealth Group ( $UnitedHealth(UNH.US$ ) , Bank of America ( $Bank of America(BAC.US$ ) , Morgan Stanley ( $Morgan Stanley(MS.US$ ) and Charles Schwab ( $Charles Schwab(SCHW.US$ ) .
Wednesday: Chip-equipment maker ASML ( $ASML Holding(ASML.US$ ) , pharm...
3
RECAP
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
42
4
High insider ownership aligns management incentives with shareholders, but recent insider share sales, especially below current price, are concerning. Lack of insider purchases over the last year adds to the unease.
1
Market optimism grows for the stock after years of progress. Despite slowing share price gains, the business may continue to execute with prowess.
Elevance Health's performance is commendable, particularly its high rate of return and significant reinvestment into its business, which has led to impressive earnings growth. Analysts expect the company's earnings to gain momentum in the future.
Read more